ArticleScientific reports2025
Dysbiosis of gut microbiota with enriched pro-inflammatory species in children with idiopathic short stature: a case-control study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gene-based burden testing implicates four novel susceptibility genes associated with isolated short stature in pediatric patients.World journal of pediatrics : WJP · 2026Article
- Metagenomic profiling of ocular surface microbiome alterations in patients with progressive supranuclear palsy-Richardson's syndrome.Current research in microbial sciences · 2026Article
- The critical role of diet, exercise, and sleep in shaping the gut microbiota of children with idiopathic short stature: a Retrospective study.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic short state (ISS) demotes a condition of diminished height in children lacking identifiable pathological etiologies, emering as a prominent elements, can precipitate ISS. We explored the prevalence, variability, organization, and contribution of gut microbiota in children affected by ISS. This study selected 58 ISS individuals aged 6-12, serving as the experimental group, 58 non-ISS children constituted the control group. Subsequent to the collection of fresh fecal specimens from both groups, 16 S rRNA gene sequencing facilitated an analysis and juxtaposition of species abundance, species richness, diversity, uniformity, structure, and composition within the intestinal microbiota of the childrens. There were significant differences in the abundance, species richness, diversity, evenness, and colony structure of gut microbiota between the two groups(P < 0.05). Compared with non-ISS children, ISS children have significantly reduced abundance, species richness, diversity, and evenness of their gut microbiota. Upon scrutinizing the gut microbiota composition, In children with ISS, there were 17 increased microorganisms and 13 decreased microorganisms at the three taxonomic levels of families, genus and species.The dominant bacteria in ISS mainly include Peptostreptococcaceae, Prevotella and Porphyromonas bennonis. The abundance, species richness, diversity, and evenness of the gut microbiota decrease, the surge in pro-inflammatory bacteria and key opportunistic pathogens, alongside the reduction of beneficial bacteria and certain opportunistic pathogens, may be linked to the occurrence and development of ISS disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.